• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Journal article

Hepatitis-B reactivation and rituximab-containing chemotherapy: An increasingly complex clinical challenge

PA Thompson, CS Tam, K Thursky, JF Seymour

Leukemia and Lymphoma | TAYLOR & FRANCIS LTD | Published : 2010

DOI: 10.3109/10428194.2010.509456

University of Melbourne Researchers

A/Prof Philip Thompson's Profile Picture
A/Prof Philip Thompson Author

Prof Constantine Tam's Profile Picture
Prof Constantine Tam Author

Prof Kas Thursky's Profile Picture
Prof Kas Thursky Author

Prof John Seymour's Profile Picture
Prof John Seymour Author

Citation metrics

7Scopus
5Web of Science
8Dimensions

Keywords

Surface-Antigen
Cancer
Digestive Diseases
3 Good Health and Well Being
Hepatitis
Risk
Science & Technology
Hepatitis - C
Hepatitis - B
Oncology
Infectious Diseases
32 Biomedical and Clinical Sciences
3201 Cardiovascular Medicine and Haematology
Preemptive Lamivudine
6.1 Pharmaceuticals
Life Sciences & Biomedicine
Liver Disease
Chronic Liver Disease and Cirrhosis
Cytotoxic Chemotherapy
Virus Reactivation
Lymphoma
Hematology
Carriers
Prophylactic Lamivudine
Emerging Infectious Diseases
Cancer-Patients
Hbv Reactivation

Acknowledgement of Country

We acknowledge Aboriginal and Torres Strait Islander people as the Traditional Owners of the unceded lands on which we work, learn and live. We pay respect to Elders past, present and future, and acknowledge the importance of Indigenous knowledge in the Academy.

Read about our Indigenous priorities

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Campus locations  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia

facebookIconlinkedinIconinstagramIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy

CRICOS number: 00116K     ABN: 84 002 705 224